Cargando…

The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort

BACKGROUND: Although patients with COPD often have various comorbidities and symptoms, limited data are available on the contribution of these aspects to health care costs. This study analyzes the association of frequent comorbidities and common symptoms with the annual direct and indirect costs of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wacker, Margarethe E, Kitzing, Katharina, Jörres, Rudolf A, Leidl, Reiner, Schulz, Holger, Karrasch, Stefan, Karch, Annika, Koch, Armin, Vogelmeier, Claus F, Holle, Rolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720349/ https://www.ncbi.nlm.nih.gov/pubmed/29270005 http://dx.doi.org/10.2147/COPD.S141852

Ejemplares similares

Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies
por: Wacker, Margarethe E., et al.
Publicado: (2016)

Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
por: Byng, Danalyn, et al.
Publicado: (2019)

Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities
por: Wacker, Margarethe E., et al.
Publicado: (2016)

Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort
por: Kahnert, Kathrin, et al.
Publicado: (2017)

Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
por: Karl, Florian M., et al.
Publicado: (2017)

Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort
por: Kahnert, Kathrin, et al.
Publicado: (2017)

Health-related quality of life associates with change in FEV(1) in COPD: results from the COSYCONET cohort
por: Lutter, Johanna I., et al.
Publicado: (2020)

Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET
por: Fischer, Carolina, et al.
Publicado: (2022)

Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review
por: Huber, Manuel B., et al.
Publicado: (2015)

Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort
por: Königsdorfer, Norbert, et al.
Publicado: (2019)

The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET
por: Kahnert, K., et al.
Publicado: (2020)

Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort
por: Alter, Peter, et al.
Publicado: (2019)

Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences
por: Lutter, Johanna I, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
por: Kahnert, Kathrin, et al.
Publicado: (2021)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
por: Greulich, Timm, et al.
Publicado: (2018)

Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review
por: Huber, Manuel B., et al.
Publicado: (2015)

Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study
por: von Siemens, Sarah Marietta, et al.
Publicado: (2019)

Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: results from COSYCONET
por: Alter, Peter, et al.
Publicado: (2020)

Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort
por: Lutter, Johanna I, et al.
Publicado: (2020)

Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohort
por: Alter, Peter, et al.
Publicado: (2023)

Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET
por: Kellerer, Christina, et al.
Publicado: (2021)

Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET
por: Alter, Peter, et al.
Publicado: (2022)

Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
por: Kahnert, Kathrin, et al.
Publicado: (2021)

Was haben wir aus der deutschen COPD-Kohorte COSYCONET gelernt und wie geht es weiter?
por: Kahnert, Kathrin, et al.
Publicado: (2022)

Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication
por: Lucke, Tanja, et al.
Publicado: (2016)

The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort
por: von Siemens, Sarah Marietta, et al.
Publicado: (2019)

Associations of oxygenated hemoglobin with disease burden and prognosis in stable COPD: Results from COSYCONET
por: Trudzinski, F. C., et al.
Publicado: (2020)

Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study
por: Lutter, Johanna I., et al.
Publicado: (2019)

Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET
por: Trudzinski, Franziska C., et al.
Publicado: (2022)

The association of smoking status with healthcare utilisation, productivity loss and resulting costs: results from the population-based KORA F4 study
por: Wacker, Margarethe, et al.
Publicado: (2013)

Health-related quality of life and chronic obstructive pulmonary disease in early stages – longitudinal results from the population-based KORA cohort in a working age population
por: Wacker, Margarethe E, et al.
Publicado: (2014)

Influence of body mass on predicted values of static hyperinflation in COPD
por: Alter, Peter, et al.
Publicado: (2018)

Are community-living and institutionalized dementia patients cared for differently? Evidence on service utilization and costs of care from German insurance claims data
por: Schwarzkopf, Larissa, et al.
Publicado: (2013)

Heterogeneous pattern of differences in respiratory parameters between elderly with either good or poor FEV(1)
por: Karrasch, Stefan, et al.
Publicado: (2018)

Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities
por: Trudzinski, Franziska C., et al.
Publicado: (2021)

What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study
por: Karrasch, Stefan, et al.
Publicado: (2016)

Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
por: Fähndrich, Sebastian, et al.
Publicado: (2017)

Association of physical activity with lung function in lung-healthy German adults: results from the KORA FF4 study
por: Luzak, Agnes, et al.
Publicado: (2017)

Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data
por: Schwarzkopf, Larissa, et al.
Publicado: (2012)

Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data
por: Stöber, Alisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5kven5juh2ms6o4empkjj9c3k7